Cardiovascular risk assessment of the general population at a community pharmacy setting


  • Uchenna I.H Eze Department of Clinical Pharmacy & Biopharmacy, Faculty of Pharmacy, Olabisi, Onabanjo University, Sagamu, Ogun State, Nigeria
  • Michael S.C Eze Faculty of Pharmacy, University of Benin, Benin City, Nigeria
  • Chinonyerem Iheanacho Department of Clinical Pharmacy & Public Health, Faculty of Pharmacy, University of Calabar, Calabar, Nigeria
  • Patrick Igbinaduwa Faculty of Pharmacy, University of Benin, Benin City, Nigeria



Cardiovascular risk, Community pharmacy, Hypertension, Nigeria, Screening


Background: The increasing burden of cardiovascular diseases (CVDs) suggests the need for early detection of risks. This study assessed the outcomes of community pharmacy-based screening for CVD risks and the association of sociodemographic characteristics with health parameters.

Methods: A cross-sectional study was conducted among healthy consumers of community pharmacy services aged 18 and above. Interventions included the measurement of blood pressure, waist-to-hip ratio, height/weight, visceral fat, and CVD risks. Study endpoints were outcomes of community pharmacy-based screenings and the association of sociodemographics with health parameters.

Results: A high prevalence of elevated blood pressure 212 (53.1%), high visceral fat 167 (41.8%), high waist-to-hip ratio 176 (44.1%), and high body mass index (BMI) 251 (62.9%) were observed among the 400 study participants. Of the 152 (38.0%) with CVD risks, 84 (55.3%) had a medium risk. Age was statistically significant for CVD risks, blood pressure, heart rate, and BMI. Occupation was statistically significant for CVD risks and heart rate. Marital status was significantly associated with CVD risk.

Conclusion: Several outcomes were observed, including a high prevalence of hypertension, high BMI, waist-to-hip ratio, and overall medium CVD risks. These findings suggest the need for increased and targeted educational interventions.


Adegoke, O., Awolola, N. A., & Ajuluchukwu, J. (2018). Prevalence and pattern of cardiovascular-related causes of out-of-hospital deaths in Lagos, Nigeria. African Health Science, 18(4), 942–949.

Adeloye, D., Ige-Elegbede, J. O., Ezejimofor, M., Owolabi, E. O., Ezeigwe, N., Omoyele, C., Mpazanje, R. G., Dewan, M. T., Agogo, E., Gadanya, M. A., Alemu, W., Harhay, M. O., Auta, A., & Adebiyi, A. O. (2021). Estimating the prevalence of overweight and obesity in Nigeria in 2020: A systematic review and meta-analysis. Annals of Medicine, 53(1), 495–507.

Adje, D. U., Oparah, C. A., Williams, F. E., & Ezeagwuna, O. O. (2016). Assessment of point of care testing services in community pharmacies in Delta state, Nigeria. Journal of Science and Practice of Pharmacy, 3(1), 115–120.

Alfadl, A. A., Alrasheedy, A. A., & Alhassun, M. S. (2018). Evaluation of medication counselling practices at community pharmacies in Quassim region, Saudi Arabia. Saudi Pharmaceutical Journal, 26(2), 258–262.

Aluh, D. O., & Norberg, M. M. (2020) Community pharmacists as a resource in task-shifted interventions for depression. The Lancet Psychiatry, 7(5), e24.

Amadi, C., Lawal, F., Ajiboye, W., Agbim, R., Mbakwem, A., Ajuluchukwu, J., Oke, D. A. (2020). Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: A cross-sectional study. International Journal of Clinical Pharmacy, 42(6), 1469–1479.

Aparecida Silveira, E., Vaseghi, G., de Carvalho Santos, A. S., Kliemann, N., Masoudkabir, F., Noll, M., Mohammadifard, N., Sarrafzadegan, N., & de Oliveira, C. (2020). Visceral obesity and its shared role in cancer and cardiovascular disease: A scoping review of the pathophysiology and pharmacological treatments. International Journal of Molecular Science, 21(23), 9042.

Chukwu, C. E., Ebuehi, O. A. T., Ajuluchukwu, J. N. A., & Olashore, A. H. S. (2021). Anthropometric, socio-demographic and biochemical risk factors of hypertension in Lagos, Nigeria. Alexandra Journal of Medicine, 57(1), 44–51.

Dokunmu, T. M., Yakubu, O. F., Adebayo, A. H., Olasehinde, G. I., & Chinedu. S. N. (2018). Cardiovascular risk factors in a suburban community in Nigeria. International Journal of Hypertension, 2018, Article 6898527.

Ejim, E. C., Okafor, C. I., Emehel, A., Mbah, A. U., Onyia, U., Egwuonwu. T., & Akabueze, J., & Onwubere, B. J. (2011). Prevalence of cardiovascular risk factors in middle-aged and elderly population in a Nigerian rural community. Journal of Tropical Medicine, 2011, 308687.

Fonseca, A. A., Lima, T. M., Castel-Branco, M., & Figueiredo, I. V. (2021). Feasibility of cardiovascular risk screening in Portuguese community pharmacies. Pharmacy Practice (Granada), 19(2), 2255.

Ghazali, S. M., Seman, Z., Cheong, K. C., Cheong, K. C., Hock, L. K., Manickman, M., Kuay, L. K., Yusoff, A. F., Mustafa, F. I., & Mustafa, A. N. (2015). Sociodemographic factors associated with multiple cardiovascular risk factors among Malaysian adults. BMC Pub Health, 15, Article 68.

Gupta, R. D., Tamanna, N., Siddika, N., Haider, S. S., Apu, E. H., & Haider, M. R. (2023). Obesity and abdominal obesity in Indian population: Findings from a nationally representative study of 698,286 Participants. Epidemiologia (Basel), 4(2), 163–172.

Iheanacho, C. O., & Adam, V. Y. (2020). Prevalence and pattern of misuse of over-the-counter drugs among teachers in public and private secondary schools in Benin City, Nigeria. Journal of Science and Practice of Pharmacy, 7(1), 383–390.

Iheanacho, C. O., & Odili, V. U. (2021a). Predominant sources of pharmacists’ drug information, and identification of drug information needs of pharmacists in community and hospital settings. Indian Journal of Pharmacy Practice, 14(1), 46–53.

Iheanacho, C. O., & Odili, V. U. (2021b). Job satisfaction among pharmacists practicing in Benin City, Nigeria. Tropical Journal of Pharmaceutical Research, 20(8), 1721–1728.

Iheanacho, C. O., Osoba, D. O., & Eze, U. I. H. (2021). Evaluation of predominant risk factors for diabetes mellitus among out-patients in two Nigerian secondary health facilities. African Health Science, 21(2), 693–701.

Ijezie, J. C., Chuku, A., Onyeonoro, U. U., Okpechi, I. G., Madukwe, O. O., Umeizudike, T. I., & Ogah, O. S. (2013). Prevalence of diabetes of abdominal obesity in Abia state, Nigeria: Results of a population-based house-to-house survey. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2013(6), 285–291.

Jahangard-Rafsanjani, Z., Hakimzade, N., Sarayani, A., Najafi, S., Heidari, K., & Javadi, M. R. (2017). A community pharmacy-based cardiovascular risk screening service implemented in Iran. Pharmacy Practice (Granada), 15(2), 919.

Katzmarzyk, P. T., Reeder, B. A., Elliot, S., Joffres, M. R., Pahwa, P., Raine, K. E., Kirkland, S. A., & Paradis, G. (2012). Body mass index and risk of cardiovascular disease, cancer and all-cause mortality. Canadian Journal of Public Health, 103(2), 147–151.

Khan, S. S., Ning, H., Wilkins, J. T., Allen, N., Carnethon, M., Berry, J. D., Sweis, R. N., & Lloyd-Jones, D. M. (2018). Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity. JAMA Cardiology, 3(4), 280–287.

Rahman, M. S., Ahmed, F. M. S., & Zafreen, F. (2019). Association of risk factors of coronary heart diseases and socio-demographic characteristics of civil employees of combined military hospital Dhaka. JAFMC Bangladesh, 15(2), 177.

Raosoft Inc. (n.d). Sample size calaculator by Raosoft Inc. Retrieved 17 February 2019, from

Smith, L. (2005). New AHA Recommendations for Blood Pressure Measurement. American Family Physician, 72(7), 1391–1398.

Smith, M., Christiano, E., & Staynor, J. M. D. (2021). Obesity and visceral fat in Indonesia: An unseen epidemic? A study using iDXA and surrogate anthropometric measure. Obesity Research in Clinical Practice, 15(1), 26–32.

Staiano, A. E., Reeder, B. A., Elliott, S., Joffres, M. R., Pahwa, P., Kirkland, S. A., Paradis, G., & Katzmarzyk, P. T. (2012). Body mass index versus waist circumference as predictors of mortality in Canadian adults. International Journal of Obesity (Lond), 36(11), 450–1454.

Tekin, C. S. (2020). The role of community pharmacists in public health and public health-related problems which they encounter. Istanbul Journal of Pharmacy, 50(2), 142–148.

Wallis, A., Rivers, P., Gray, L. J. Davies, M., & Khunti, K. (2014). The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting. PLoS ONE, 9(4), e91157.

World Health Organisation. (2021). Cardiovascular diseases (CVDs). Retrieved from December 24, 2021.




How to Cite

Eze, U. I., Eze, M. S., Iheanacho, C., & Igbinaduwa, P. (2024). Cardiovascular risk assessment of the general population at a community pharmacy setting. Pharmacy Education, 24(1), p. 348–355.



Research Article